Bladder cancer Board decisions

The Board denied an earlier effective date for the award of service connection and a higher initial rating for recurrent bladder cancer with voiding dysfunction.

The Board denied the claims for an earlier effective date and a compensable rating for bladder cancer and prostate cancer, as service connection was granted under the PACT Act on August 10, 2022.

The Board denied the veteran's claim for service connection for bladder cancer, finding no evidence that it was incurred in or is etiologically related to active service.

The Board is remanding the issues of service connection for bladder cancer, prostate cancer, and diabetes mellitus for readjudication.

The Board granted service connection for hypertension based on a presumption of chronicity and continuity of relevant symptomatology, as the evidence is at least in equipoise.

The Board remands the claims for service connection for bladder cancer, hypertension, anxiety, depression, and erectile dysfunction due to a need for further evidence regarding herbicide exposure in Korea.

The Board granted restoration of a 100 percent rating for bladder cancer with urinary dysfunction from July 1, 2024.

The issues of entitlement to restoration of basic eligibility for DEA benefits and an additional compensable rating for diabetic nephropathy were withdrawn by the Veteran, and are therefore dismissed.

The Board granted service connection for bladder cancer, resolving all doubt in the Veteran's favor and finding that his bladder cancer is as likely as not caused by exposure to toxic materials, including radiation, during active service.

The Board remands the service connection claims for bladder cancer, hypertension, anxiety, depression, and erectile dysfunction due to a pre-decisional duty-to-assist error regarding herbicide exposure in Korea.

The Board remands the claim for a new examination to assess the current severity of the Veteran's service-connected bladder cancer status post resection surgery due to alleged worsening symptoms.

The Board granted service connection for bladder cancer, colorectal adenomas, and a left toe condition based on new and relevant evidence that the Veteran's conditions were caused by exposure to toxic chemicals during his service at Fort McClellan.

The Board granted service connection for kidney and bladder cancer, as well as the removal of the left kidney due to a service-connected disability.

The Board granted service connection for prostate cancer due to herbicide exposure and denied an increased rating for bladder cancer.

The Board remands the claims for an increased rating for bladder cancer residuals and for consideration of a TDIU due to a failure to provide a VA examination.

The Board remands the claims for an initial compensable rating for bladder cancer and entitlement to TDIU due to a pre-decisional duty to assist error, requiring further evidence and medical opinion.

The Board granted service connection for bladder cancer based on the Veteran's exposure to tactical herbicides in Thailand, as supported by the PACT Act.

The Board remands the claims for service connection for hypertension, prostate cancer, bladder cancer, and bilateral hearing loss due to a pre-decisional duty to assist error.

The Board denied the veteran's claims for increased ratings and earlier effective dates, finding that the evidence did not support higher evaluations or earlier dates of entitlement.

The Board granted an effective date of April 8, 2019, for service connection for bladder cancer and denied a higher rating for the same condition. The claims for erectile dysfunction and insomnia were remanded.